Hutchings M, Sureda A, Bosch F, Larsen TS, et al. Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial. J Clin Oncol 2025 Oct 20:JCO2500992. doi: 10.1200/JCO-25-00992.
PMID: 41115257